Excellence in life sciences executive search

The Chase Group Partners with Eli Lilly to Find Medical Affairs Expertise in Breast Cancer

May 25, 2017
Eli Lilly has retained The Chase Group to secure Medical Affairs Talent for their US Oncology Medical Affairs team for their promising CDK 4/6 molecule, Abemaciclib, in advanced breast cancer. This is a key leadership position within the medical group with responsibility to lead and build the US Abema Medical Affairs team. Lilly is focused on recruiting a physician that knows how to practice the art of medical affairs in a contemporary way to drive and deliver this product launch. For consideration, please contact Moira Newbanks at 913-663-3100 or moira@chasegroup.com.

Chase Group

Share this Content

Copyright © 1993-2024 The Chase Group. All Rights Reserved.